Clovis Oncology

Five Biotech Stocks That Could Be M&A Targets After the Selloff
Barron's
Tue, 09/29/15 - 10:30 pm
biotech
M&A
Merrimack
OncoMed
Clovis Oncology
Pfenex
Baxter
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Yahoo/Benzinga
Tue, 09/15/15 - 09:04 am
biotech
Gilead Sciences
Akebia
Vitae
Clovis Oncology
AstraZeneca
Bristol-Myers Squibb
Flexion
Tetraphase Pharmaceuticals
These Clinical-Stage Biotechs Could Be Ripe for a Takeover
Motley Fool
Mon, 09/14/15 - 08:15 am
biotech
M&A
Portola Pharmaceuticals
Clovis Oncology
Trevena
This Past Week’s Top 5 Biotech Movers
24/7 Wall St
Sat, 09/12/15 - 01:31 pm
biotech
Akebia Therapeutics
Clovis Oncology
Mirati Therapeutics
Vivus
Vitae
Clovis leaps as AstraZeneca's AZD9291 disappoints on lung cancer
Fierce Biotech
Thu, 09/10/15 - 05:54 pm
Clovis Oncology
AstraZeneca
AZD9291
non-small cell lung cancer
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
Biotech Clovis Oncology raising $275 million for new cancer drugs
Bizjournals.com
Wed, 07/8/15 - 09:48 am
Clovis Oncology
rucaparib
cancer
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
ASCO
Oncothyreon
Immunogen
Bristol-Myers Squibb
Merck
Clovis Oncology
Roche
CTI BioPharma
Celldex Therapeutics
Puma Biotechnology
Express Scripts
ASCO 15: The top 10 setbacks, advances and head scratchers
Fierce Biotech
Mon, 06/1/15 - 12:15 pm
ASCO
Celldex Therapeutics
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Clovis Oncology
AstraZeneca
Genentech
Clovis Wins One ASCO '15 Battle, Loses Another, Against Rival AstraZeneca
TheStreet.com
Mon, 06/1/15 - 09:41 am
Clovis Oncology
ASCO
rucaparib
AstraZeneca
Lynparza
rociletinib
AZD9291
Clovis Oncology’s Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Highly Compelling Clinical Activity
Yahoo
Sat, 05/30/15 - 05:41 pm
Clovis Oncology
ASCO
rucaparib
ovarian cancer
Why Clovis is Getting Clobbered
Barron's
Sun, 05/17/15 - 01:51 pm
Clovis Oncology
T790M
Clovis Jumps After Hours On Accelerated Review Of Ovarian Cancer Drug
Barron's
Mon, 04/6/15 - 06:12 pm
Clovis Oncology
rucaparib
ovarian cancer
Clovis Lung Cancer Update Swings Momentum to Rival, Slightly
TheStreet.com
Wed, 11/19/14 - 10:08 am
Clovis Oncology
AstraZeneca
rociletinib
lung cancer
The Battle For Lung Cancer Drugs Continues
Bidness Etc.
Tue, 10/7/14 - 01:45 pm
lung cancer
AstraZeneca
Clovis Oncology
AZD9291
CO-1686
AstraZeneca Whale Racing With Minnow to Develop Lung Cancer Drug
Bloomberg
Wed, 10/1/14 - 09:32 pm
AstraZeneca
Clovis Oncology
lung cancer
Clovis Shares Higher on Improved Outlook for Lung Cancer Drug
TheStreet.com
Mon, 09/29/14 - 06:41 pm
Clovis Oncology
lung cancer
AZD9291
rociletinib
Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiat
Yahoo/BusinessWire
Sun, 09/28/14 - 09:39 am
rucaparib
ovarian cancer
Clovis Oncology
Why Clovis Oncology Was Up 10% In After-Hours Trading Yesterday
Bidness Etc.
Thu, 09/11/14 - 08:20 am
Clovis Oncology
breast cancer
Lucitanib

Pages